 - Patients with an active bleeding diathesis or on concurrent or prior within 7 days of enrollment therapeutic anti-coagulation therapy with warfarin, heparin, or low molecular weight heparin; the use of low-dose warfarin 2 mg orally PO daily for prophylaxis against central venous catheter thrombosis is allowed 